September Meeting and Vendor Night

Speaker: Eric Fischer, Harvard Medical School

Topic: Systematic discovery of Molecular Glue Degraders from scalable platforms to therapies

Date: Monday, September 21, 2026

Time: 6:00 pm Dinner and Vendor Night, 7:15 pm Presentation

Location: Shimadzu Scientific Instrument, Inc. Training Center 7100 Riverwood Drive, Columbia, MD 21046 (Directions)

Dinner: Please RSVP to Mamie Lih (mamielih@gmail.com) by Friday, September 18 if you will be attending the dinner.

Abstract: In recent years, the co-opting of ubiquitin ligases by small molecules for the targeted protein degradation of disease-causing proteins has emerged as a powerful pharmacologic modality. While the discovery of PROTACs has become a mainstay of drug discovery, discovery of novel molecular glue degraders particularly beyond CRBN modulators remains a major challenge for the field. I will present recent work on understanding the principles that govern molecular glue interactions, updates on our discovery platforms and recent examples of success to target novel and previously undruggable neo-substrates and to expand the repertoire of ligases enabled for molecular glues. I will specifically discuss our advances in high-throughput structural biology to rapidly enable discovery programs and enable fine tuning of machine learning models to prioritize hits.

June Meeting

Topic: Post-ASMS Poster Night and ASMS Travel Award Presentations
All attendees are invited to put up an ASMS poster

Date: Monday, June 15, 2026

Time: 6:15 pm Dinner and ASMS posters, 7:30 pm Presentations

Location: Shimadzu Scientific Instrument, Inc. Training Center 7100 Riverwood Drive, Columbia, MD 21046 (Directions)

Dinner: Please RSVP to Sheng Feng (SFeng@som.umaryland.edu) by Friday, May 12 if you will be attending the dinner.

ASMS Travel Award Recipients:

    • Vanshika Patel, University of Maryland, School of Pharmacy:

: “DIA-Based Phosphoproteomics Defines AP-1 Signaling Dynamics Driving Remodeling in Airway Epithelial Cells”

    • Adrian Coello, University of Virginia

: “On-Tissue Chemical Derivatization Using 1-Amino-4-Methylpiperazine for DESI-MSI of Neuroactive Steroids in a Substance Use Disorder Rat Model”

    • Ailing Li, University of Maryland

: “Hydraplexing: Signal Amplification via Additive Fragment Ion Contributions from Multi-Tag Isobaric Labeling”

    • Mirandia Szramowski, University of Maryland, School of Pharmacy

: “Strategies for Integrating Strong Anion Exchange Chromatography with Mass Spectrometry for Oligonucleotide Analysis”

May Meeting

Speaker: Lisa Jenkins, National Cancer Institute

Topic: Investigation into the Mechanism and Targets of an Antiviral Zinc Finger Inhibitor

Date: Monday, May 11, 2026

Time: 6:15 pm Dinner, 7:15 pm Presentation

Location: Shimadzu Scientific Instrument, Inc. Training Center 7100 Riverwood Drive, Columbia, MD 21046 (Directions)

Dinner: Please RSVP to Sheng Feng (SFeng@som.umaryland.edu) by Friday, May 9 if you will be attending the dinner.

Abstract: Covalent modification of target proteins is a well-established mechanism of action for small molecule inhibitors. Cysteine residues in particular have been exploited for their reactivity toward electrophilic molecules. SAMT-247 is a mercaptobenzamide thioester that covalently acetylates cysteines in the zinc-coordinating domains of the HIV nucleocapsid (NC) protein. We have used mass spectrometry to investigate the mechanism of viral inactivation of NC by SAMT-247, identifying multiple sites of covalent modification that resulted from SAMT reaction. This SAMT-247-promoted reaction leads to loss of zinc binding by the protein, with concomitant loss of protein structure and function. Although it has low cytotoxicity in animal models, recent studies have indicated that it affects other protein targets in uninfected cells, for example leading to increased immune cell functions. We have used global proteomics approaches have been used to better understand other protein targets of SAMT-247 in THP-1 cells. Although minimal effects are observed when unstimulated THP-1 monocyte cells were treated with SAMT-247, many potential targets were identified when the THP-1 cells were stimulated with phorbol 12-myristate 13-acetate/Ionomycin (PMA/Iono) before SAMT-247 treatment. Among the affected proteins, several with zinc-coordinating domains and/or reactive cysteine residues were found. Further study of reaction of SAMT-247 with two potential targets verified that they are modified by the inhibitor. The increased effects of SAMT-247 in stimulated immune cells suggests that this molecule could be developed to target diseases other than HIV.

Lightning Talk
Automatic Blood Protein Enrichment by Magnetic-COF Polymers
Yuanyu Huang, Johns Hopkins University

Abstract: Blood proteome is a highly informative biological fluid, reflecting physiological and pathological states across the entire body. Automated Magnetic-COF workflow achieves deep, reproducible, and scalable blood proteome profiling across plasma, serum, and whole blood, with reduced dominance of high-abundance proteins and improved access to low-abundance species. The platform maintained low variability and broad physicochemical coverage without introducing major enrichment bias, which enabled identification of more than 4000 blood proteins with the throughput of 30 samples per day. Applied to a 110-sample PDAC serum cohort, it delivered stable cohort-scale performance, identified clinically relevant differential proteins, and highlighted biomarker candidates such as APOE and CEACAM5 with promising diagnostic value. Collectively, these findings establish Magnetic-COF–based automation as a robust strategy for high-throughput blood proteomics and translational biomarker discovery in PDAC.

April Meeting

Speaker: Christopher A. LeClair, National Center for Advancing Translational Sciences (NCATS), NIH

Topic: How Many Samples!?: Automation Facilitates High-Throughput Sample Preparation for Analytical Analysis

Date: Monday, April 13, 2026

Time: 6:15 pm Dinner, 7:15 pm Presentation

Location: Shimadzu Scientific Instrument, Inc. Training Center 7100 Riverwood Drive, Columbia, MD 21046 (Directions)

Dinner: Please RSVP to Sheng Feng (SFeng@som.umaryland.edu) by Friday, April 10 if you will be attending the dinner.

Abstract: The endeavor of increasing experimental capacity to reduce the therapeutic discovery and development timeline has heavily focused on throughput and cycle time. Most advancements center on improvements to instrument sensitivity, sampling time, sample size, data processing speed, and data quality, enabling thousands of samples to be analyzed down to a seconds per sample time scale while generating large, information-rich datasets. However, sample preparation remains a bottleneck as methods and protocols tend to be manual, time-consuming, and often disconnected from research workflows. The Analytical Chemistry Core (ACC) within the Division of Preclinical Innovation (DPI) at NCATS has leveraged automation technologies to develop innovative platforms for higher throughput in sample purification, processing, and preparation. This initiative has resulted in chromatography and mass spectrometry standardized workflows and processes that not only increase experimental capacity but reduce operational inefficiencies. To provide effective purification support in an efficient and expedient manner, the ACC developed a centralized liquid chromatography sample purification and processing platform for the rapid progression of crude reaction mixtures to purified compounds. This platform facilitates the addition of thousands of compounds annually to the NCATS compound library. Furthermore, we successfully developed an automated, high-throughput 384-well plate format sample preparation platform for the reproducible extraction of proteins from cells for MS-based proteomics. The platform is highly adaptable, being applied to the isolation and analysis of other substrates of interest (i.e., lipids, metabolites), as well as using other biological source materials such as human-derived (i.e., serum) and whole organism (i.e., C. elegans). The continued development and optimization of automated platforms will allow us to readily accommodate the handling, preparation, and analysis for large numbers of varied samples, providing greater analytical support to research programs.

Lightning Talk
Enhancing Spatial Biology with Atmospheric and Vacuum MALDI Platforms
Francine Yanchik-Slade, Ph.D.
Shimadzu Scientific Instruments

Abstract: Mass spectrometry imaging (MSI) has emerged as a powerful analytical technique for visualizing the spatial distribution of biomolecules within complex samples, offering critical insights for spatial omics, drug distribution studies, and molecular diagnostics. Shimadzu provides a comprehensive, fully integrated MALDI-based imaging workflow that supports every stage of the process, from matrix application through data acquisition and advanced data analysis. To accommodate diverse experimental needs, Shimadzu offers both atmospheric-pressure and vacuum MALDI platforms. The iMScope QT combines high-resolution atmospheric-pressure MALDI with a built-in optical microscope, enabling precise co-registration and ensuring accurate targeting of regions of interest. Complementing this, the MALDI-80X0 delivers robust, high-throughput MALDI imaging performance in a compact benchtop format suited for any laboratory environment. This presentation will highlight real-world applications of these systems that are advancing spatial omics and driving innovation through streamlined imaging workflows.